<scp>SARS‐CoV</scp> ‐2 triggers complement activation through interactions with heparan sulfate
Martin W. Lo(The University of Queensland), Trent M. Woodruff(The University of Queensland), Alberto A. Amarilla(Commonwealth Scientific and Industrial Research Organisation), Daniel Watterson(The University of Queensland), Eduardo A. Albornoz(The University of Queensland), Richard J. Clark(The University of Queensland), Vito Ferro(The University of Queensland), Naphak Modhiran(The University of Queensland), Mohit Chhabra(The University of Queensland), John D. Lee(The University of Queensland), Alexander A. Khromykh(The University of Queensland)
Cited by 20
Related Papers
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
|Molecular Psychiatry|2022|178
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
|Nature Communications|2021|177
Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design
|Biochemical Journal|2006|170
PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models
|British Journal of Cancer|2011|165
Processed foods drive intestinal barrier permeability and microvascular diseases
|Science Advances|2021|152